Cytek Biosciences (CTKB) Treasury Shares (2020 - 2025)

Cytek Biosciences' Treasury Shares history runs 6 years deep, the most recent figure standing at $5.1 million for Q2 2025.

• Quarterly Treasury Shares changed 0.13% year-over-year to $5.1 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $5.1 million (changed 0.13% YoY) and the FY2023 annual result came in at $2.6 million, up 123.02% from the prior year.
• Treasury Shares was $5.1 million for Q2 2025 at Cytek Biosciences, up from $4.6 million in the prior quarter.
• Across five years, Treasury Shares topped out at $87.3 million in Q1 2021 and bottomed at $104876.0 in Q4 2021.
• A 5-year average of $14.1 million and a median of $3.1 million in 2023 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2021 — Treasury Shares slumped 99.88% — and 2022, when it surged 1015.13%.
• Cytek Biosciences' Treasury Shares stood at $104876.0 in 2021, then jumped by 1015.13% to $1.2 million in 2022, then soared by 123.02% to $2.6 million in 2023, then soared by 77.45% to $4.6 million in 2024, then rose by 11.16% to $5.1 million in 2025.
• Business Quant data shows CTKB's Treasury Shares at $5.1 million in Q2 2025, $4.6 million in Q3 2024, and $5.2 million in Q2 2024.